Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 702

1.
2.

Outcomes of thromboprophylaxis with enoxaparin vs. unfractionated heparin in medical inpatients.

McGarry LJ, Stokes ME, Thompson D.

Thromb J. 2006 Sep 27;4:17.

PMID:
17005045
[PubMed]
Free PMC Article
3.

Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis.

Roderick P, Ferris G, Wilson K, Halls H, Jackson D, Collins R, Baigent C.

Health Technol Assess. 2005 Dec;9(49):iii-iv, ix-x, 1-78. Review.

PMID:
16336844
[PubMed - indexed for MEDLINE]
Free Article
4.

Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients.

McGarry LJ, Thompson D, Weinstein MC, Goldhaber SZ.

Am J Manag Care. 2004 Sep;10(9):632-42.

PMID:
15515996
[PubMed - indexed for MEDLINE]
Free Article
5.

Cost effectiveness of enoxaparin as prophylaxis against venous thromboembolic complications in acutely ill medical inpatients: modelling study from the hospital perspective in Germany.

Schädlich PK, Kentsch M, Weber M, Kämmerer W, Brecht JG, Nadipelli V, Huppertz E.

Pharmacoeconomics. 2006;24(6):571-91.

PMID:
16761905
[PubMed - indexed for MEDLINE]
6.

Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.

Kanaan AO, Silva MA, Donovan JL, Roy T, Al-Homsi AS.

Clin Ther. 2007 Nov;29(11):2395-405. Review.

PMID:
18158080
[PubMed - indexed for MEDLINE]
7.

Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.

Huo MH, Muntz J.

Clin Ther. 2009 Jun;31(6):1129-41. doi: 10.1016/j.clinthera.2009.06.002. Review.

PMID:
19695383
[PubMed - indexed for MEDLINE]
8.

Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: methodology for the EXCLAIM study.

Hull RD, Schellong SM, Tapson VF, Monreal M, Samama MM, Turpie AG, Wildgoose P, Yusen RD.

J Thromb Thrombolysis. 2006 Aug;22(1):31-8.

PMID:
16786230
[PubMed - indexed for MEDLINE]
9.

[Two models of thromboprophylaxis in acutely ill medical inpatients].

Luba M, Firek A, Kochanowski Z.

Pol Arch Med Wewn. 2007 Apr;117(4):31-7. Polish.

PMID:
17722473
[PubMed - indexed for MEDLINE]
Free Article
10.

Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis.

Själander A, Jansson JH, Bergqvist D, Eriksson H, Carlberg B, Svensson P.

J Intern Med. 2008 Jan;263(1):52-60. Review.

PMID:
18088252
[PubMed - indexed for MEDLINE]
11.
12.

Thromboprophylaxis in medical patients: the role of low-molecular-weight heparin.

Turpie AG, Norris TM.

Thromb Haemost. 2004 Jul;92(1):3-12. Review.

PMID:
15213839
[PubMed - indexed for MEDLINE]
13.

A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group.

Samama MM, Cohen AT, Darmon JY, Desjardins L, Eldor A, Janbon C, Leizorovicz A, Nguyen H, Olsson CG, Turpie AG, Weisslinger N.

N Engl J Med. 1999 Sep 9;341(11):793-800.

PMID:
10477777
[PubMed - indexed for MEDLINE]
Free Article
14.

Identifying orthopedic patients at high risk for venous thromboembolism despite thromboprophylaxis.

Schiff RL, Kahn SR, Shrier I, Strulovitch C, Hammouda W, Cohen E, Zukor D.

Chest. 2005 Nov;128(5):3364-71.

PMID:
16304285
[PubMed - indexed for MEDLINE]
15.

Inpatient and outpatient occurrence of deep vein thrombosis and pulmonary embolism and thromboprophylaxis following selected at-risk surgeries.

Amin AN, Lin J, Thompson S, Wiederkehr D.

Ann Pharmacother. 2011 Sep;45(9):1045-52. doi: 10.1345/aph.1Q049. Epub 2011 Aug 23.

PMID:
21862717
[PubMed - indexed for MEDLINE]
16.

Thromboprophylaxis in medically ill patients at risk for venous thromboembolism.

Burleigh E, Wang C, Foster D, Heller S, Dunn D, Safavi K, Griffin B, Smith J.

Am J Health Syst Pharm. 2006 Oct 15;63(20 Suppl 6):S23-9.

PMID:
17032931
[PubMed - indexed for MEDLINE]
17.

Economic evaluation of enoxaparin as prophylaxis against venous thromboembolism in seriously ill medical patients: a US perspective.

de Lissovoy G, Subedi P.

Am J Manag Care. 2002 Dec;8(12):1082-8.

PMID:
12500884
[PubMed - indexed for MEDLINE]
Free Article
18.
19.

Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.

Kahn SR, Panju A, Geerts W, Pineo GF, Desjardins L, Turpie AG, Glezer S, Thabane L, Sebaldt RJ; CURVE study investigators.

Thromb Res. 2007;119(2):145-55. Epub 2006 Mar 3.

PMID:
16516275
[PubMed - indexed for MEDLINE]
20.

Enoxaparin for thromboprophylaxis after major trauma: potential cost implications.

Shorr AF, Ramage AS.

Crit Care Med. 2001 Sep;29(9):1659-65.

PMID:
11546959
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk